-
AI opportunities in GU Cancers
November 12, 2022Looking to the future, Prof. Arnulf Stenzl (DE), Prof. Alberto Briganti (IT) and Dr. Bob Schijvenaars (NL) chaired the...
00 -
New trial results for PEACE-1, OpeRa, and adjuvant therapies in high-risk RCC
November 12, 2022A selection of new trial results were shared and discussed in Plenary Session 5 on day three of EMUC22....
-
Plenary Session 3 report: New strategies in BCa
November 11, 2022After a day full of supplementary meetings like ESUI22 and the YAU’s Autumn Meeting, day two of EMUC22 saw...
-
Diagnosing PCa – what’s the best option?
November 11, 2022The objective of the 14th European Multidisciplinary Congress on Urological Cancers is to work together to achieve the best...
-
What’s new in GU Pathology and WHO classification?
November 10, 2022The Uropathology Symposium (ESUP) delivered the latest updates on the WHO classification of genito-urinary tract tumours for 2022, and...
-
ESUI22: Examining the near future of imaging
November 10, 2022The 10th Meeting of the EAU Section of Urological Imaging got off to a good start on Thursday, 10 November,...
-
The parallels to mountaineering are everywhere, even in urology
September 27, 2022Vital updates on major trials, emerging technologies, and pioneering techniques will be featured during the 14th European Multidisciplinary Congress...
-
EMUC22 Preview: “Treatment intensification in mHSPC is a hot topic right now”
September 5, 2022The 14th European Multidisciplinary Congress on Urological Cancers (EMUC22) is coming to Budapest, Hungary, from the 10 to 13 November...
-
EMUC22: Relevant topics and Prof. Stenzl’s personal highlights
June 27, 2022Year after year since 2008, the European Multidisciplinary Congress on Urological Cancers (EMUC) provides the urological community with integrative...
-
Recap of EMUC21: The take-home messages
November 30, 2021Being an event with a multidisciplinary nature, the take-home messages of the 13th European Multidisciplinary Congress on Urological Cancers...
News
EMUC22 > News
